PACS Group, Inc.

PACS · NYSE · ·

Karşılaştır

$48,32+%0,613 Kas kapanış

30 Eylül 2026 tarihine kadarki rakamlar, 3 Kasım 2026 tarihinde sunulan 10-Q raporundan

1W: -%2,6
1M: +%1,2

Just reported

Q3 2026 results

From PACS's results release of 3 Kasım 2026; its quarterly report has since been filed.

Revenue
Actual
$1,5B
+%11 y/y
+%4,9 q/q
Guided
—
No guide given
EPS, GAAP
Actual
$0,37
+%16 y/y
-%21 q/q
Guided
—
No guide given
Operating income, GAAP
Actual
$99,7M
+%16 y/y
-%8,8 q/q
Guided
—
No guide given

Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.

Keep exploring

The themes PACS is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.

Highest-graded in Medical Care Facilities

Graded A or B and worth $2B or more: A first, then the largest.

All 44 graded companies in its industry

Grade rose recently in Healthcare

Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.

All grade rises

Tüm finansal tablolar →

PACS Group, Inc. şirketinin ABD Menkul Kıymetler ve Borsa Komisyonu’na (SEC) sunduğu kendi belgelerinden kuruldu. Rakamlar bildirildiği gibidir; hisse başına geçmiş bugünkü hisse tabanına göre yeniden hesaplanmıştır. Bu bir işletmeyi anlatır — yatırım tavsiyesi değildir ve alma ya da satma önerisi değildir.

PACS Group, Inc.

PACS Group, Inc.

Q3 2026 results

Revenue

EPS, GAAP

Operating income, GAAP

Keep exploring

Highest-graded in Medical Care Facilities

Grade rose recently in Healthcare

Q3 2026 results

Revenue

EPS, GAAP

Operating income, GAAP

Keep exploring

Highest-graded in Medical Care Facilities

Grade rose recently in Healthcare

Büyüme ve nakit — 5 üzerinden 5

İş eğilimi

Zaman içinde hisse fiyatı ve not